ARTICLE | Company News
Empagliflozin gets CHMP nod
March 22, 2014 12:54 AM UTC
EMA's CHMP backed approval of Jardiance empagliflozin from Boehringer Ingelheim GmbH (Ingelheim, Germany) and partner Eli Lilly and Co. (NYSE:LLY) as an adjunct to diet and exercise to improve glycemi...